Search

Your search keyword '"Neuenschwander, FC"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Neuenschwander, FC" Remove constraint Author: "Neuenschwander, FC"
14 results on '"Neuenschwander, FC"'

Search Results

1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

3. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

4. Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO 2 Requirements.

5. Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial.

7. Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.

8. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.

9. Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers.

11. One year follow-up Assessment of Patients Included in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT).

13. Use of evidence-based interventions in acute coronary syndrome - Subanalysis of the ACCEPT registry.

14. Clinical outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT).

Catalog

Books, media, physical & digital resources